Seres is set to receive up to $3.6m in further non-dilutive funding from the international non-profit partnership, CARB-X.

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...

Lifecore Biomedical and PolyPeptide Laboratories have linked to deliver an end-to-end peptide manufacturing solution for US ...

European biotechs should leverage its innovation and collaborate with Asian manufacturing hubs to secure greater investment, ...

Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

MHLW of Japan has granted orphan regenerative medicine product designation to Kyowa Kirin and Orchard Therapeutics’ MLD therapy..

In the complex and challenging field of early-phase clinical trials, logistics specialists are vital. A recent podcast spoke ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...